What Researchers Did
A comprehensive literature search was conducted using PubMed and Google Scholar to review articles published between November 2021 and January 2024 on long COVID and hyperbaric oxygen therapy.
What They Found
The reviewed literature, encompassing case series and randomized trials, consistently demonstrated that Hyperbaric Oxygen Therapy (HBO) provided significant improvement in patients with long COVID. These studies collectively suggest HBO as a safe and potentially beneficial treatment option for this population.
What This Means for Canadian Patients
Hyperbaric Oxygen Therapy may offer a new avenue for managing persistent symptoms in Canadian patients suffering from long COVID, where effective treatments are currently lacking. However, further research is needed to establish its widespread clinical application and availability.
Canadian Relevance
This study does not have a direct Canadian connection.
Study Limitations
The review synthesized findings from various study types, including case series, which may present limitations regarding the overall strength and generalizability of the evidence.